SCHEMBL6502483

SCHEMBL6502483

Cc1cc(-n2cc(NC(N)=O)c(C(N)=O)n2)ccc1-c1ccc(O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.41
NPC1 O15118 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HSD17B1 P14061 1/20 0.37
KDM4E B2RXH2 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
F10 P00742 1/20 0.36
CLK1 P49759 1/20 0.36
DYRK1A Q13627 1/20 0.36
DYRK2 Q92630 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499099 0.91 ITK (0.42) ITKNPC1ALDH1A1HSD17B1KDM4E
SCHEMBL6468674 0.89 ITK (0.43) ITKNPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6499994 0.87 ITK (0.39) ITKNPC1ALDH1A1HSD17B1KDM4E
SCHEMBL6499580 0.87 ITK (0.39) ITKNPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6507365 0.87 ITK (0.38) ITKNPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6502100 0.86 SCN9A (0.45) ITKALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL6500174 0.86 ITK (0.41) ITKNPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6498693 0.85 KDM4E (0.46) ITKNPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6468202 0.85 ITK (0.43) ITKNPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL6499437 0.85 ITK (0.40) ITKNPC1ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885NPC1 3546/4885ALDH1A1 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.